There have been many changes in the field of coagulation during
the past decade. New concepts of epidemiology of risk factors for
thrombosis now help clinicians predict who is more likely to form
clots after surgery, or after being placed on oral contraceptives.
New anticoagulants have the potential to redefine how patients with
atrial fibrillation and venous thrombosis are managed. There are
new forms of recombinant clotting factors which have changed our
approach to hypofibrinogenemia and von Willebrand s disease. Newer
antiplatelet agents are available and their use in patients
receiving cardiac stents has mushroomed. The management of
thrombosis in the setting of pregnancy has changed over the past
decade, as well as the way clinicians approach women with multiple
miscarriages. An entire new class of compounds, the
thrombopoietins, are available to treat individuals with immune
thrombocytopenic purpura (ITP).
"The Coagulation Consult"covers major topics of interest to
hematologists who are asked to consult on individuals with
coagulation related diseases, and encompasses the field s most
recent developments. This case-directed book describes
state-of-the-art approaches to patients with bleeding and clotting
disorders, as well as laboratory tests for coagulation. Chapters
include different vignettes, focus on typical clinical consult
questions, and lay out specific types of treatment. Practicing
clinicians being confronted withcoagulation consult students,
residents, fellows and attending physicians will find this unique
text an invaluable resource for some of the newer areas of
coagulation science, therapy and pharmacology."
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!